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This Month in the Journal
This month in the Journal, Jay Gargus contributes a
review on monogenic channelopathies. Therein, he de-
tails the current understanding of this class of disorders,
which may involve a range of organ systems, including
the heart, skeletal muscle, or CNS. Dr. Gargus also ar-
gues that the genes involved in these channelopathies be
considered as candidate genes for a range of polygenic
disorders of the CNS.
Geography of Ashkenazi Mutations, by Risch et al. (p.
812)
Four lysosomal storage disorders (LSDs) affecting glyco-
sphingolipids are found at an elevated frequency in the
Ashkenazi Jewish population. Many have argued that
this must be due to a carrier advantage that leads to
maintenance of the causative mutations in the popula-
tion. Others have suggested that the increased frequency
is simply due to a founder effect and genetic drift. Risch
et al. tease this apart through comparisons of LSDs with
non-LSDs, in terms of their mutation frequency, coales-
cence times, and geographic distributions. No obvious
differences were found between the groups for any of
these parameters, as would have been expected if an LSD
mutation were under different selective forces than the
other mutations. Highly disparate geographic distribu-
tions can be found for mutations within single disease
entities, which further supports a role for randomgenetic
drift, rather than selection, in the distribution of these
mutations.
PKCg Mutations in SCA, by Chen et al. (p. 839)
Expansions of coding and noncoding repeat tracts are
responsible for nine different forms of spinocerebellar
ataxia (SCA), but there are additional forms of SCA for
which no underlying genetic explanation has yet been
found. Chen et al. recently mapped a locus for a new
form of cerebellar ataxia to chromosome 19q13.4-qter in
one family. Among the 1300 genes in this region,PRKCG,
which encodes PKCg, was a compelling candidate gene
for several reasons, including the fact that it is highly
expressed in Purkinje cells of the cerebellar cortex, the
major component of the CNS that exhibits degeneration
in this disorder. Missense mutations were found in two
affected families, including the one used to define the lo-
cus, and one sporadic case of SCA. Proteinmodeling stud-
ies predict that two of the three mutations, which were
all found at conserved residues in exon 4, would affect
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protein function. Immunohistochemical studies on cere-
bellar tissue from an affected individual indicate that, in
addition to low levels of PKCg, there is a reduction in
expression ofATX1, the gene involved in SCA1.Although
these results support a new mechanism for the develop-
ment of SCA that does not involve repeat tract expan-
sions, they also suggest a possible link between the path-
way leading to this form of SCA and those associated
with other forms of this disorder.
Phenotypes Associated with Deletions of 17p13.3, by
Cardoso et al. (p. 918)
Deletions of 17p13.3 cause a range of phenotypes, from
isolated lissencephaly sequence (ILS) to the more complex
phenotype Miller-Dieker syndrome (MDS). Although ILS
generally does not include dysmorphic features beyond
lissencephaly, individuals affected with MDS have facial
dysmorphism and a range of congenital anomalies, in
addition to a more severe grade of lissencephaly than is
generally seen in ILS. Although haploinsufficiency for
LIS1 is involved in both disorders, it cannot explain the
more severe grade of lissencephaly, nor the additional
components of the MDS phenotype. To uncover the ge-
netic differences between ILS and MDS, Cardoso et al.
characterized 34 individuals with deletions of 17p13.3,
including some with ILS, MDS, or no lissencephaly. They
generated a detailed physical map of the region and used
it to compare deletions from individuals with different
phenotypes. This allowed them to define a 400-kb critical
region that differentiates ILS from MDS. Within this re-
gion are eight genes that are consistently deleted inMDS,
including two genes, CRK and 14-3-3, that are deleted
in individuals with the most severe grade of lissencephaly.
Because a mouse model has implicated 14-3-3 in cortical
development, Cardoso et al. speculate that deletions of
this gene, possibly in combination with CRK, contribute
to the more severe form of lissencephaly.
hTERT Haploinsufficiency in CdCS, by Zhang et al. (p.
940)
The telomerase reverse transcriptase (hTERT) gene is
located in the same general region of chromosome 5p
that is deleted in Cri-du-Chat syndrome (CdCS), a syn-
drome characterized by such things as psychomotor and
mental retardation,microcephaly, and a characteristic cat-
like cry in newborns. Zhang et al. found that, indeed, one
copy of hTERT was deleted in all 10 individuals with
CdCS whom they examined. This haploinsufficiencywas
associated with decreased hTERT expression and accel-
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erated telomere shortening in lymphocytes from the af-
fected individuals. Because progressive loss of telomeres
limits cellular replication in vitro, Zhang et al. examined
the proliferation potential of cells from the individuals
with CdCS and found that they did have impaired rep-
licative capacity, as indicated by a reduced number of
population doublings before the cells became senescent.
This loss of replicative capacity was rescued through
expression of hTERT from a viral vector. In addition to
premature senescence, CdCS-derived cells exhibited an
age-dependent increase in chromosomal abnormalities,
specifically chromosome fusions, that seem likely to re-
sult from the loss of telomeres. These hTERT-haploin-
sufficient cells should serve as a useful model for studies
of in vivo telomerase function, as well as the role of the
hTERT deficiency in the phenotype of CdCS.
The mtDNA Mutation A3243G, by Torroni et al. (p.
1005)
The mtDNAmutation A3243G is associated with a wide
range of phenotypes, from maternally inherited diabetes
and deafness to the severe MELAS syndrome. The fac-
tors influencing phenotypic expression of this mutation
are unknown. Torroni et al. studied 35 unrelated Spanish
carriers of A3243G, who had a range of phenotypes, to
determine whether the mtDNA background onwhich this
mutation is found influences the phenotypic expression
of the mutation. In this group, the A3243G mutation
was found on 34 individual haplotypes, indicating that
the mutation arose independently in almost all cases.
The lack of evidence for a founder mutation in this pop-
ulation suggests that A3243G is a severely deleterious
mutation that is under negative selection. There was also
no evidence that groups of individuals with a particular
phenotype had mutations that clustered on a specific hap-
logroup, suggesting that the haplogroup on which
A3243G is located does not influence the phenotypic
expression of this mutation.
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